Dowling-Degos disease: a review

dc.contributor.authorStephan, Carla
dc.contributor.authorKurban, Mazen S.
dc.contributor.authorAbbas, Ossama M.
dc.contributor.departmentDermatology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:40:50Z
dc.date.available2025-01-24T11:40:50Z
dc.date.issued2021
dc.description.abstractDowling-Degos disease is a rare autosomal dominant genodermatosis. It is characterized by acquired reticulate hyperpigmentation over the flexures, comedone-like follicular papules, and pitted perioral scars that usually develop during adulthood. Mutations in genes affecting melanosome transfer, and melanocyte and keratinocyte differentiation have been implicated in the pathogenesis of this disease. These genes include KRT5, POFUT1, POGLUT1 and, most recently, PSENEN. Dowling-Degos disease can be found in isolation or with other associated findings, most notably hidradenitis suppurativa. This condition belongs to a spectrum of conditions that all result in reticulate hyperpigmentation that at times are hard to distinguish from each other. The most closely linked entity is Galli-Galli, which is clinically indistinguishable from Dowling-Degos disease and can only be distinguished by the presence of acantholysis on microscopy. Unfortunately, Dowling-Degos disease is generally progressive and recalcitrant to treatment. © 2020 the International Society of Dermatology
dc.identifier.doihttps://doi.org/10.1111/ijd.15385
dc.identifier.eid2-s2.0-85099520308
dc.identifier.pmid33368260
dc.identifier.urihttp://hdl.handle.net/10938/29591
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofInternational Journal of Dermatology
dc.sourceScopus
dc.subjectAcantholysis
dc.subjectAdult
dc.subjectAmyloid precursor protein secretases
dc.subjectGlucosyltransferases
dc.subjectHumans
dc.subjectHyperpigmentation
dc.subjectMembrane proteins
dc.subjectSkin diseases, genetic
dc.subjectSkin diseases, papulosquamous
dc.subjectCytokeratin 5
dc.subjectGlucosyltransferase
dc.subjectMembrane protein
dc.subjectPoglut1 protein, human
dc.subjectPsenen protein, human
dc.subjectSecretase
dc.subjectCell differentiation
dc.subjectCell transfer
dc.subjectClinical feature
dc.subjectDifferential diagnosis
dc.subjectDisease association
dc.subjectDisease exacerbation
dc.subjectDowling degos disease
dc.subjectEpiluminescence microscopy
dc.subjectGalli galli disease
dc.subjectGene
dc.subjectGene mutation
dc.subjectGenetic screening
dc.subjectGenodermatosis
dc.subjectGenotype phenotype correlation
dc.subjectHistopathology
dc.subjectHuman
dc.subjectIntense pulsed light therapy
dc.subjectKeratin 5 gene
dc.subjectKeratinocyte
dc.subjectLaser therapy
dc.subjectMelanocyte
dc.subjectMelanosome
dc.subjectMicroscopy
dc.subjectPapule
dc.subjectPathogenesis
dc.subjectPresenilin enhancer protein 2 gene
dc.subjectProtein o fucosyltransferase 1 gene
dc.subjectProtein o glucosyltransferase 1 gene
dc.subjectReview
dc.subjectScar
dc.subjectSuppurative hidradenitis
dc.subjectTopical treatment
dc.subjectErythematosquamous skin disease
dc.subjectGenetics
dc.subjectSkin disease
dc.titleDowling-Degos disease: a review
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-5994.pdf
Size:
569.72 KB
Format:
Adobe Portable Document Format

Collections